Since direct contact with BTN3A1-expressing tumor cells alone does not bestow suppressive activity onto Vδ2+ T cells, further studies are needed to comprehensively identify what exactly activates Vδ2+ T cells and how activation translates into various specific effector functions. This evidence concerns the gene BTN3A1 and neoplasm.